Skip to content

Baseline levels and influencing factors of TMAO, TMAVA, and precursor TML in healthy adults

Baseline levels and influencing factors of TMAO, TMAVA, and precursor TML in healthy adults

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300078223
Enrollment
Unknown
Registered
2023-12-01
Start date
2023-12-01
Completion date
Unknown
Last updated
2023-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular disease, heart disease, kidney disease, diabetes

Interventions

Trail group:Not

Sponsors

Nanning Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Voluntarily sign an informed consent form and provide truthful information.

Exclusion criteria

Exclusion criteria: ? (Interview) Those who have or are suffering from cardiovascular and cerebrovascular diseases (including coronary heart disease, hypertension, stroke, peripheral arterial and vascular diseases, rheumatic heart disease, congenital heart disease and heart failure), diabetes, chronic kidney disease, and malignant tumors; ? (Consultation) Those who have undergone major surgery within one month before sampling; ? (Consultation) Those who have used antibiotics within 3 months before sampling; ? (Consultation) Those who cannot tolerate venous puncture and/or have a history of blood or needle sickness; ? (Laboratory examination) Patients with abnormal electrocardiogram, systolic and diastolic blood pressure, fasting blood glucose, serum creatinine, serum urea nitrogen, serum uric acid, white blood cell and neutrophil counts determined by doctors to have clinical significance; ? Sampling may not be possible due to other reasons.

Design outcomes

Primary

MeasureTime frame
Trimethylamine oxide;trimethyllysine;N, N, N-trimethyl-5-aminovaleric acid;

Countries

China

Contacts

Public ContactLei Yuyan

Nanning Second People's Hospital

leiyuyan23@163.com+86 152 7807 5866

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026